Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 31,389 | 16,426 | 11,621 | 5,941 | 35,729 |
| Operating Income | -31,389 | -16,426 | -11,621 | -5,941 | -35,729 |
| Other Income | 9 | -403 | -2,554 | -2,205 | -1,096 |
| Pre-tax Income | -31,380 | -16,829 | -14,175 | -8,146 | -36,825 |
| Net Income Continuous | -31,380 | -16,829 | -14,175 | -8,146 | -36,825 |
| Net Income | $-31,380 | $-16,829 | $-14,175 | $-8,146 | $-36,825 |
| EPS Basic Total Ops | -0.97 | 32.81 | -8.96 | -5.54 | -27.26 |
| EPS Basic Continuous Ops | -0.97 | 32.81 | -8.96 | -5.54 | -27.26 |
| EPS Diluted Total Ops | -0.97 | 32.81 | -8.96 | -5.54 | -27.26 |
| EPS Diluted Continuous Ops | -0.97 | 32.81 | -8.96 | -5.54 | -27.26 |
| EBITDA(a) | $-31,231 | $-16,268 | $-11,462 | $-5,724 | $-35,616 |